Novo Nordisk Shares Plunge on Insulin's FDA Failure
Feb. 11 (Bloomberg) -- Bloomberg's Caroline Hyde reports that Novo Nordisk shares have fallen the most in a decade as the company's new insulin drug Tresiba has failed to win FDA approval in the United States. She speaks on Bloomberg Television's "The Pulse."
Tsipras: Won’t Be Clash or Kowtowing With Creditors
Jan. 29 -- Greek bank stocks rebounded as the government moved to contain the fallout from pledges made by its ministers, seeking to downplay the prospect of an imminent clash with creditors. Bloomberg’s Michael McKee reports on “Bloomberg Surveillance.”
Spongebob: Who Lives in a Pineapple on Your TV?
Truck Drivers Protest Wages and Block Traffic
Arab Spring and Failed States: Charlie Rose (01/29)